Magis SpA
MIL:MGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
|
CA |
|
Geely Automobile Holdings Ltd
HKEX:175
|
HK |
|
Prima Alloy Steel Universal Tbk PT
IDX:PRAS
|
ID |
|
W
|
Worthington Steel Inc
NYSE:WS
|
US |
|
Vocento SA
MAD:VOC
|
ES |
|
K
|
Karman Holdings Inc
NYSE:KRMN
|
US |
|
LVMH Moet Hennessy Louis Vuitton SE
XETRA:MOH
|
FR |
Wall St Price Targets
MGS Price Targets Summary
Magis SpA
According to Wall Street analysts, the average 1-year price target for MGS is 13.13 EUR with a low forecast of 12.88 EUR and a high forecast of 13.65 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MGS's stock price target?
Price Target
13.13
EUR
According to Wall Street analysts, the average 1-year price target for MGS is 13.13 EUR with a low forecast of 12.88 EUR and a high forecast of 13.65 EUR.
What is the Revenue forecast for Magis SpA?
Projected CAGR
5%
Over the last 4 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Magis SpA?
Projected CAGR
26%
Over the last 4 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for Magis SpA?
Projected CAGR
18%
Over the last 4 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 3 years is 18%.
